EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: Data from the National Registry of Myocardial Infarction 2



Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: Data from the National Registry of Myocardial Infarction 2



Journal of the American College of Cardiology 32(2): 360-367



Objectives: This study was undertaken to examine recent trends in the use of angiotensin-converting enzyme (ACE) inhibitor therapy in patients discharged after acute myocardial infarction (AMI) and to identify clinical factors associated with ACE inhibitor prescribing patterns. Background: Clinical trials have demonstrated a significant mortality benefit in patients treated with ACE inhibitors after AMI. Numerous studies have demonstrated underuse of other beneficial treatments for patients with AMI, such as beta-adrenergic blocking agents, aspirin and immediate reperfusion therapy. Methods: Demographic, procedural and discharge medication data from 190,015 patients with AMI were collected at 1,470 U.S. hospitals participating in the National Registry of Myocardial Infarction 2. Results: Prescriptions for ACE inhibitor therapy at hospital discharge increased from 25.0% in 1994 to 30.7% in 1996. Patients with a left ventricular ejection fraction <40% or evidence of congestive heart failure while in the hospital were discharged with ACE inhibitor treatment 42.6% of the time. Of patients experiencing an anterior wall myocardial infarction and no evidence of heart failure, 26.1% of patients were discharged with this treatment. Of the remaining patients, 15.6% received ACE inhibitors at discharge. ACE inhibitors were prescribed more often to elderly and diabetic patients as well as those requiring intraaortic balloon pump placement. This therapy was given less often to patients who underwent revascularization with coronary angioplasty or coronary artery bypass graft surgery or were treated with calcium channel blocking agents. Conclusions: Physicians are prescribing ACE inhibitors in patients with myocardial infarction with increasing frequency. Those patients with the greatest expected benefit receive ACE inhibitor treatment most often. However, the majority of even these high risk patients were not discharged with this life-saving therapy.

(PDF emailed within 0-6 h: $19.90)

Accession: 009703776

Download citation: RISBibTeXText

PMID: 9708461

DOI: 10.1016/s0735-1097(98)00225-3



Related references

Early use of ACE inhibitors in the treatment of acute myocardial infarction in the United States: experience from the National Registry of Myocardial Infarction 2. National Registry of Myocardial Infarction 2 participants. American Journal of Cardiology 84(10): 1176-1181, 1999

Comparative Effectiveness of Angiotensin II Receptor Blockers Versus Angiotensin-Converting Enzyme Inhibitors Following Contemporary Treatments in Patients with Acute Myocardial Infarction: Results from the Korean Working Group in Myocardial Infarction (KorMI) Registry. American Journal of Cardiovascular Drugs 15(6): 439-449, 2016

The clinical characteristics of dialysis patients with acute myocardial infarction in the United States A collaborative project of the United States Renal Data System /NIH and the National Registry of Myocardial Infarction. Circulation 108(17 Supplement): IV-377, October 28, 2003

Clinical characteristics of dialysis patients with acute myocardial infarction in the United States: a collaborative project of the United States Renal Data System and the National Registry of Myocardial Infarction. Circulation 116(13): 1465-1472, 2007

Lack of adverse long-term prognostic effect of aspirin therapy in patients treated with angiotensin converting enzyme inhibitors after myocardial infarction Results from a nationwide French registry of acute myocardial infarction. Journal of the American College of Cardiology 37(2 Supplement A): 274A, February, 2001

ASS, Beta Blocker and angiotensin-converting enzyme inhibitors as an initial therapy for acute myocardial infarction Results from the Berlin Myocardial Infarction Registry. European Heart Journal 23(Abstract Supplement): 726, August-September, 2002

Early use of ACE inhibitors in the treatment of acute myocardial infarction in the United States: Experience from the National Registry of Myocardial Infarction 2. American Journal of Cardiology 84(10): 1176-1181, Nov 15, 1999

Utilization of reperfusion therapy for acute myocardial infarction in the United States Data from the National Registry of Myocardial Infarction 2. Circulation 96(8 SUPPL ): I203, 10/21/97, 1997

Regional variation in the treatment of women with acute myocardial infarction in the United States Data from the National Registry of myocardial infarction 2. Circulation 96(8 SUPPL ): I536, 10/21/97, 1997

Use of reperfusion therapy for acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2. Circulation 97(12): 1150-1156, 1998

Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-converting Enzyme Inhibitor Myocardial Infarction Collaborative Group. Journal of the American College of Cardiology 35(7): 1801-1807, 2000

Use of lipid-lowering medications at discharge in patients with acute myocardial infarction: Data from the National Registry of Myocardial Infarction 3. Circulation 103(1): 38-44, January 2-9, 2001

Contemporary patterns of discharge aspirin dosing after acute myocardial infarction in the United States: results from the National Cardiovascular Data Registry (NCDR). Circulation. Cardiovascular Quality and Outcomes 7(5): 701-707, 2015

Are different angiotensin converting enzyme inhibitors identical for treatment of acute myocardial infarction? Results from the Hong-Kong post-myocardial infarction trial. European Heart Journal 20(ABSTR SUPPL ): 287, 1999

Effects of enalapril and losartan in left ventricular remodeling after acute myocardial infarction: a possible mechanism of prevention of cardiac events by angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high-risk myocardial infarction. Internal Medicine 48(11): 877-882, 2010